- Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial
- Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint
- Secarna Pharmaceuticals to announce positive new data at cancer research conference
- Qfitlia approved by FDA to treat haemophilia A or B
- Alfred Merz appointed as CEO of ProBioGen
- Medidata launches programme to accelerate therapy delivery
- Winners announced for 2025 PM Society Awards
- FDA grants fast track designation to chlamydia vaccine candidate
- Shane Olwill appointed as chief development officer at Asgard Therapeutics
- Gergely Sved appointed as CEO of Ellab
- Carole Imbert appointed as CFO of Vect-Horus
- Five of EU-27 account for 68% of pharma trade, report finds
- Pierre Fabre announces investments and partnerships in lung cancer research
- Allegro shares promising preclinical results for osteoarthritis treatment
- Pharming Group doses first patient in phase 2 trial of leniolisib in CVID